Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • PharmAust is putting a leash on canine cancer, and COVID-19
    • News

    PharmAust is putting a leash on canine cancer, and COVID-19

    From high rise city apartments to the rolling hills of the countryside, you’re likely to find a dog or two snuggled up on the living room couch. Studies have proven what us dog loving people already know- that the human-canine bond is special. Owning a dog reduces stress, alleviates anxiety and even can prolong your

    Read More
    Public
  • Track your kids, pets and seniors with geotags, Life360 to acquire Jiobit wearables
    • News

    Track your kids, pets and seniors with geotags, Life360 to acquire Jiobit wearables

    The world is not the same safe place it once was based on rising demand for location-aware safety solutions which security tech company Life360 (ASX: 360) is taking one step further through the USD $37 million acquisition of wearables company Jiobit to extend their family-tracking suite. The acquisition is part of a strategic review which

    Read More
    Public
  • Karst backs Aussie small cap following hugely successful pharma strategy
    • News

    Karst backs Aussie small cap following hugely successful pharma strategy

    Leading fund manager Karst Peak Capital has secured a significant interest in a little-known Aussie pharmaceuticals research company, following the significant success they experienced with a large holding of Avita Medical. Originally based in Hong Kong but now also with an office in Sydney, Karst’s investment focus includes the healthcare, biotech and pharmaceuticals industry which

    Read More
    Public
  • Archer secures access to $150m deep tech facility to advance nano-biochip for disease detection
    • News

    Archer secures access to $150m deep tech facility to advance nano-biochip for disease detection

    Continued emergence of graphene and its application in biotech is being led by homegrown tech company Archer Materials (ASX: AXE) which has secured access to a $150 million world-class research facility to advance their biochip development. The facility provides Archer with instruments to test its semiconductor device production processes. Key to the deep tech access

    Read More
    Public
  • How 4DMedical is changing the medtech game post COVID
    • News

    How 4DMedical is changing the medtech game post COVID

    While we are seemingly on the back-stretch of the COVID-19 pandemic, increased medical awareness has changed how we diagnose respiratory diseases with medtech company 4DMedical (ASX: 4DX) leading the charge. Their proprietary FDA/TGA approved, patented respiratory imaging platform, XV Technology turns sequences of x-ray images into four-dimensional, quantitative data to improve and accelerate diagnostic accuracy.

    Read More
    Public
  • Harris Technology lines up eCommerce expansion with $5m fundraising
    • News

    Harris Technology lines up eCommerce expansion with $5m fundraising

    One of the hottest retail stocks on the ASX with gains of more than 300% over the past year, Harris Technology (ASX: HT8) is showing no signs of slowing down with investors rushing to fund further growth as HT8 successfully completed an oversubscribed $5 million capital raise. The funding was supported by institutional and professional

    Read More
    Public
  • «
  • ‹
  • 510
  • 511
  • 512
  • 513
  • 514
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.